Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ)
CNY 6.5
(-0.31%)
CNY 6.5
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 254.75 Million | 439.99 Million | 237.88 Million | 292.75 Million | 66.21 Million | 233.59 Million |
| Net Income | 157.29 Million | 150.94 Million | 109.46 Million | 102.09 Million | 80.6 Million | 60.7 Million |
| Depreciation & Amortization | 126.31 Million | 121.7 Million | 76.78 Million | 70.85 Million | 70.55 Million | 74.81 Million |
| Deferred income taxes | -22.5 Million | -5.7 Million | -10.26 Million | 5.56 Million | -7.12 Million | -4.16 Million |
| Stock-based compensation | 53.37 Million | - | - | - | - | - |
| Change in working capital | -80.37 Million | 121.54 Million | -4.61 Million | 73.81 Million | -127.94 Million | 44.2 Million |
| Other non-cash items | 48.18 Million | 45.8 Million | 56.23 Million | 45.99 Million | 42.99 Million | 53.86 Million |
| Investing Cash Flow | -143.65 Million | -99.39 Million | -149.72 Million | -84.91 Million | -363.02 Million | -161.97 Million |
| Investments in PPE | -152.11 Million | -81.76 Million | -157.35 Million | -190.74 Million | -145.61 Million | -84.63 Million |
| Acquisitions | 7.99 Million | -302.67 Million | 1.04 Million | 4.29 Million | 145.62 Million | 1.75 Million |
| Investment purchases | - | -29 Million | -1.04 Million | -31.89 Million | -221.78 Million | -104.81 Million |
| Sales/Maturities of investments | 5.36 Million | 5.74 Million | 7.23 Million | 133.07 Million | 4.36 Million | 5.71 Million |
| Other Investing Activities | 8.45 Million | 308.3 Million | 392.18 Thousand | 357.31 Thousand | -145.61 Million | 20 Million |
| Financing Cash Flow | -165.2 Million | -262.26 Million | -106.01 Million | -209.81 Million | 287.09 Million | -11.88 Million |
| Debt repayment | -29.87 Million | -804.3 Million | -942.9 Million | -1.15 Billion | -844.99 Million | -780.7 Million |
| Dividends payments | -33.21 Million | -31.21 Million | -26.27 Million | -38.4 Million | -51.7 Million | -31.66 Million |
| Common Stock Repurchased | -347.68 Thousand | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -71.14 Million | 599.5 Million | 862.49 Million | 985.76 Million | 1.18 Billion | 800.47 Million |
| Accounts receivables | -238.77 Million | -89.25 Million | -114.07 Million | 44.77 Million | -7.73 Million | 24.86 Million |
| Accounts payables | 54.5 Million | 261.4 Million | 138.84 Million | -44.77 Million | 7.73 Million | - |
| Inventory | 126.4 Million | -44.9 Million | -42.32 Million | -40.68 Million | -23.33 Million | -58.47 Million |
| Other working capital | 31.99 Million | -5.7 Million | 12.94 Million | 114.5 Million | -104.6 Million | 102.67 Million |
| Cash at beginning of period | 344.67 Million | 266.25 Million | 252.77 Million | 255.31 Million | 265.01 Million | 205.02 Million |
| Cash at end of period | 290.73 Million | 344.67 Million | 234.57 Million | 252.77 Million | 255.31 Million | 265.01 Million |
| Capital Expenditure | -152.11 Million | -81.76 Million | -157.35 Million | -190.74 Million | -145.61 Million | -84.63 Million |
| Effect of forex changes on cash | 173.03 Thousand | 87.72 Thousand | -336.48 Thousand | -565.28 Thousand | 20.31 Thousand | 262.91 Thousand |
| Net cash flow / Change in cash | -53.93 Million | 78.41 Million | -18.19 Million | -2.54 Million | -9.69 Million | 59.98 Million |
| Free Cash Flow | 102.63 Million | 358.22 Million | 80.52 Million | 102 Million | -79.4 Million | 148.95 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 47.09 Million | 53.2 Million | 47.01 Million | 157.29 Million | 16.82 Million | 39.44 Million |
| Depreciation & Amortization | - | 34.78 Million | 34.78 Million | 126.31 Million | 126.31 Million | -61.2 Million |
| Deferred income taxes | - | - | - | -22.5 Million | - | 75.61 Million |
| Stock-based compensation | - | - | - | 53.37 Million | 17.24 Million | 17.24 Million |
| Change in working capital | - | - | - | -80.37 Million | -112.36 Million | -741.62 Thousand |
| Other non-cash items | -5.24 Million | 1.61 Million | -31.23 Million | 48.18 Million | 90.63 Million | 53.66 Million |
| Investing Cash Flow | -50.72 Million | -16.21 Million | -114.71 Million | -143.65 Million | -62.76 Million | -8.06 Million |
| Investments in PPE | -30.35 Million | -43.98 Million | -29.71 Million | -152.11 Million | -65.95 Million | -13.27 Million |
| Acquisitions | 2.76 Million | -1.68 Million | 2 Million | 7.99 Million | 7.94 Million | - |
| Investment purchases | -28 Million | - | -85 Million | - | - | - |
| Sales/Maturities of investments | 7.62 Million | 24.08 Million | - | 5.36 Million | 152.63 Thousand | - |
| Other Investing Activities | 3400.00 | 27.76 Million | -84.99 Million | 8.45 Million | 3.19 Million | 5.2 Million |
| Financing Cash Flow | 8.54 Million | -58.11 Million | 81.91 Million | -165.2 Million | 28.09 Million | -109.05 Million |
| Debt repayment | -23.74 Million | -10.11 Million | -92.4 Million | -29.87 Million | -81.53 Million | -187.5 Million |
| Dividends payments | -6.93 Million | -56.76 Million | -5.81 Million | -33.21 Million | -33.21 Million | -6.23 Million |
| Common Stock Repurchased | - | - | - | -347.68 Thousand | -347.68 Thousand | -173.84 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.27 Million | -11.47 Million | -4.67 Million | -71.14 Million | -43.69 Million | 84.68 Million |
| Accounts receivables | - | - | - | -238.77 Million | -238.77 Million | 112.77 Million |
| Accounts payables | - | - | - | 54.5 Million | - | 2.5 Million |
| Inventory | - | - | - | 126.4 Million | 126.4 Million | -113.51 Million |
| Other working capital | - | - | - | - | -1.25 Million | -2.5 Million |
| Cash at beginning of period | 216.24 Million | 273.73 Million | 290.73 Million | 344.67 Million | 203.96 Million | 233.22 Million |
| Cash at end of period | 209.98 Million | 216.24 Million | 273.73 Million | 290.73 Million | 290.73 Million | 203.96 Million |
| Capital Expenditure | -30.35 Million | -43.98 Million | -29.71 Million | -152.11 Million | -65.95 Million | -13.27 Million |
| Effect of forex changes on cash | -24.45 Thousand | 100.83 Thousand | 22.51 Thousand | 173.03 Thousand | 37.91 Thousand | -52.6 Thousand |
| Net cash flow / Change in cash | -6.25 Million | -57.49 Million | -16.99 Million | -53.93 Million | 86.77 Million | -29.26 Million |
| Free Cash Flow | 11.49 Million | -23.94 Million | -13.93 Million | 102.63 Million | 55.45 Million | 74.63 Million |
3294
4544
603219
GH
ALPA
WKGBF